|
|
|
|
|
| Particulars |
2021 |
% |
2020 |
% |
2019 |
% |
| Ethical Products |
91,817,897 |
76.0% |
87,702,796 |
74.0% |
98,421,936 |
70.9% |
| OTC Products |
7,780,783 |
6.4% |
7,392,240 |
6.2% |
8,163,761 |
5.9% |
| Export |
5,844,180 |
4.8% |
5,021,942 |
4.2% |
6,163,474 |
4.4% |
| Others |
15,424,053 |
12.8% |
18,328,286 |
15.5% |
26,009,231 |
18.7% |
| Total |
120,866,913 |
100.0% |
118,445,264 |
100.0% |
138,758,402 |
100.0% |
| Ethical products are SCD's core business, constituting about 85% of total net sales |
(Unit : Thousand Won) |
| Product name |
Category |
2021 |
% |
2020 |
% |
2019 |
% |
| Hameron Eye drops |
Ophthalmology |
22,005,951 |
24.0% |
22,443,704 |
25.6% |
26,598,037 |
27.0% |
| Tari-S Tab. |
Respiratory/ENT |
1,145,571 |
1.2% |
1,047,335 |
1.2% |
1,558,093 |
1.6% |
| Clamox Tab. |
Antibiotics |
1,051,469 |
1.1% |
1,299,272 |
1.5% |
2,473,950 |
2.5% |
| Atolow Tab. |
CV/Endocrinology |
2,318,637 |
2.5% |
1,346,748 |
1.5% |
1,653,712 |
1.7% |
| Barotase Tab. |
Musculoskeletals |
368,544 |
0.4% |
378,421 |
0.4% |
677,277 |
0.7% |
| Others |
|
64,927,725 |
70.7% |
61,187,316 |
69.8% |
65,460,867 |
66.5% |
| Total |
|
91,817,897 |
100.0% |
87,702,796 |
100.0% |
98,421,936 |
100.0% |
Our main brands in the OTC drug market are well recognized among Korea OTC market
And Iris eye drop(Artificial tears), Sodam Cap(Antitussive expectorants),
Bincluded Narista-S Nasal spry (Nasal congestion remedies).
|
(Unit : Thousand Won) |
| Product name |
Indication |
2021 |
% |
2020 |
% |
2019 |
% |
| Iris eye drop |
Artificial tears(dry eye) |
1,061,384 |
13.6% |
1,133,347 |
15.3% |
1,356,561 |
16.6% |
| Sodam Cap.
| Antitussive expectorants
| 222,057 |
2.9% |
234,329 |
3.2% |
428,431 |
5.2% |
| Narista-S Nasal spray |
Decongestants
(allergic rhinitis) |
337,349 |
4.3% |
372,545 |
5.0% |
297,544 |
3.6% |
| Others |
|
6,159,993 |
79.2% |
5,652,019 |
76.5% |
6,081,225 |
74.5% |
| Total |
|
7,780,783 |
100.0% |
7,392,240 |
100.0% |
8,163,761 |
100.0% |
|
|
